ࡱ> Root EntryRoot Entrygw$FileHeaderDocInfo\ BodyText ,RСR  !"#$%&'()*+HwpSummaryInformation.TPrvImage PrvTextDocOptions gwgwScripts gwgwJScriptVersion DefaultJScript_LinkDoc  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSUVWXYZ[]^_`abcdefghijklmnopqrstuvwxyz{|}~<T\19 txƄ t $ ­> <; ( <><c$ ޹ t $   ><><> <><><><><>< a$ ­ ><><> <><><><><><><> <0><`$ ­ Ȝ !><><KoNECT>< ><8><><><><b$ $ ) ! ><><> <><><><><><><>> <­0><0 ><><\ԐDž><><Ő]8><><H֘t><>< ><><Tֈ8><><Ȕ Ȉ>< 1) 2) 3)><乜a(ܭ)><> <Ēǐ (­0)><1 ><><4T><>< ><><e-mail><>< T><><) ><> % ml, ȵԩ / 8( ) (\ 3D tǴ) <8><ȅ><><lD ()><l0 (0-L)><`>< Ǭ ŀ><l> <1><><><><><><><> <2><><><><><><><> <3><><><><><><><> <4><><><><><><><> <5><><><><><><><> * l :  ‰ ,  ‰D̸ \ lX 0/ ` :  Ēǐ ,  l <\ lX 0 % Ȕ (\ 3D tǴ) <8>< ȩ>< Ĭ><SIT/IIT><IND ŀ><IRB ŀ><m/m> <1><><><><><><> <2><><><><><><> <3><><><><><><> <4><><><><><><> <5><><><><><><> <6><><><><><><> * SIT(Sponsor-initiated Trial): Xǰ ij l, IIT(Investigator-initiated Trial): l ij l * IND(Investigational New Drug): ˆX}ňHȘ Ĭ x­ * IRB(Institutional Review Board): ¬ƌ % 0  <* >GIF89aɻxxxkkk]]]PPPCCC555((( d`LH00`Hذ̘`H0|pdXL@`0H `H0`dHL`H0xp`XH@0d LȰ``HH00dLؘȀ`H0xp`XH@d0L `H0d`LH`H0|pdXL@0`$H`dHL00`HذȘdL0xp`XH@0` HdH0ȳ``HHdL0xp`XH@`0H Ը̰ĠऀؘpȈXxHp@h@d8`8X0xT0pH dxddxd`d`p`|``x`p``x`!, H*\ȰÇ#JHŋ3jȱǏ CIɓ(S\ɲ˗0cʜI͛8sɳϟ@ JѣH*]ʴӧPJJիXjʵׯ`ÊKYҪ]˶۷pʝKݻpAX߿ ^;`|61b;&ȏ- Y/}BfLzoM֢Vm2<5ߧ}wԾ Y?<9mOSg>lQӞZ7y)KV;vav_wݶvq]Yw-ހ9gyE׃F(uօfJv RbDI'caHR0,DH(5ģ^=ZctAV4GGP1#.2FCfIqbRn@WTa9Vyh#9ie H"ofl `8(Og^4%! 9z^b K&jJj-Rijufp:I>)(J~\. ^ D0*`&kbIgFKJkmԶإ2+g %F*+( ot-ԻH*.滬R oZ ?n0bn-k^ w%=ϋ._1ovs /o+}sC"z4$-lZrjdVۙ1Y׷~S;]( v=ތ2 .]/ZWH^mMx?.y嘇O_~W^G~:ѩXqŷF޺\!]z ^ʓ~8UtMω==}~3O~O>~Cd'vcSlwY| >H?4{H¢? N*g@s6<0z.8Iɪ%7_T8)H] "@ B+R$_E1,L݀3ޓƳAl"g}߷Ozi)!`{` H>"RSTi?vηك_kxeQBv%h^J\5VMQ(eMοe-(GZn}F;ҿ۹\صIaMj[خ=CuXвEN inuϥbm˺4@$F7nuw\ ڒ?pwx-Ou涛GefiS1~h 9$ K+.WWMgd1 Yk1ЗFu<6qd?]>9WGybv.vh_2eCL~搷Mdoȹ5])ϻQ^t[n1۱tWu{m{)xZ!>;9O]{#y>_j=I?lTWE|KS}M7osPnZ4дW+^ַ><;t9Q}?ҿʠ}~0\O|&mI1Q}~fi瀓vh Ȁ~iF|xv~",6hC)& ehkO8W}+t!~,XQ]Ɓ@B8DXFxHJL؄NPR8TXVxX*;^R1K_{exhjl؆npr8S;`a``a`0x ( l x  % mlUser2020D 11 12| | $ 4:39:05user8, 0, 0, 466 WIN32LEWindows_7@@Ƹ@СR@VJQ=ޙAKy! 7.D4 ͨ1ZhE7>@Z"XRƅ"̝Lf& ";ܟ̜}^S|Gi {boblyc=`T%Q+{n&^%,bLepَ5}"@ 2$fHI ϓ&t-l Կ_4b7cxxjŃ4V $Section0?>v, .zQ2<#5]z[ņ1Y޳izB`/9eN2Ok|> -kbX8Zxy`pNabbb01q#RODо!A5nm9岞8Df?K hab&$/ݖ$\PŽ*PC:ҫڔvV[|l^xXuAU !Iˎؔ8Ӫ! V1N1\%J~x@JxEP$4yE<"sY߭ˉrf3=;>0t.$,U4*xX3kRX>̡VKJf La3ss`Sf8dt0] .sp\ФLIW6搬P>1f'N&e.D,(m|L fg*+mnwm66+;,RJ$vX=!>~Ρ<`'j!Wjg+vQl|VBD{K?@;| H+k?E 王.;Yvg IH$c@N0X={"2Tإi vR*-EHhδ3Qk m12U]= edu{l*{\bzv`e6CJ9bF=<Ul܂N OF=ɜ7L׏99Vk5a2{&V"Azy)]{ ֯jYVY{^~УN[xyi/vz~ Fm.c!J<><><><> <5><><><><><><> <6><><><><><><> * SIT(Sponsor-initiated Trial): Xǰ ij l, IIT(Investigator-initiated Trial): l ij l * IND(Investigational New Drug): ˆX}ňHȘ Ĭ x­ * IRB(Institutional Review Board): ¬ƌ % 0  <* >u@DO 6C,H,#GB!k0~ 6*7=M*Z:ҙ#?*?ӿT@Y~X+mj3'm[v|:j)%C$Mϼ5#cd߈><><><> <4><><><><><><> <5><><><><><><> <6><><><><><><> * SV=LA~3U!& xK4hBq MD-,Ԩ1$4Xp&*??!B ##9r3c7{ Y  ܍OmK >8ta{\Э;|C;nuqix> gy}v6A޶t^- m$vU|x~?`0D/̓ց0tIZuM7gnޒ={R=d:Bj_Rk~kEܕr׺ Axda&O= pϗ_]{!a]shoR9 %R;6V4D S,ΆۤV w0-_ I<HV#Cq4I1 QVSņo Q< m̩7>BA]8*JMN&K#яqs{(㘧6s>Nc'Ap= {L\22L{|2VxSw'SOϿ!Rh-GSXp/{%z HƓtنgco뿄l*ީYE")աY!jJo(lcSdv 2pLU& ӨG J;B+*`rOtGhQ- =E/t.暊`rM c=nEI00O%lCl\TjjEԋކ(Kqa,]ɧӊ Ԋ c->(/VPQ:ViBPY:VJX+C@uʐ0x55%*C*;n~P=rRn ly%F%QSCQ6ZPQD;55 Z\UVU٭\ݿrVĕMHTQϽ#92:3r"fP…9 A"ZAk3-\k3 AQ40 hE -º_#oyy罿?{ 44k>:쾖6\pơ 311ºk HVb6ɟm )3$,n^H@B.1"%x!^ÿ66i k cԔ T^眪)aU. ,b~v\OW M\לu<%@u/GW@Z]Y1#\8^A- ܲoк]1헽%6ear  ʢEhhb)qgo*y*\H_z(s?*`& w& +ք~T&$m;@@}v.(@}}BoyCD`ޟʏSɚs9C{^CՆgI1L1'tȏu)U{Cd)LNMŽ,黤ao#]G8yH!] u.98+;r9ԠXj-5jc=4MzhX8Iq$N̅r9\@;S8a 4R~ Ih[Q()uvX=A8kE'(g=TAJ4ybH.2\nvwϖ2s R$~|.AJ4vI%ɭͩP)](쒦]fG10*c[YrF8G8ug`ĖOHQǿ3vwR;2]uvZEQCV:]U(:xm`ࡠC vE*FVࡃ/zͬ;3;3 oY~3{}\t_J" tp!`tճGN) ЫA? OE?\EW ttu TgA=P Tjъz.yt2;ɑo՗Xގ.FX ? e^cbƂ)ԟVET'w-p8QͩS݉؃X"U5GhlBbݪ TH p^c=ʽ/H{P !G7ns="mfp??H,p?\VQ$ u#qGܦ33qz#>;OO?j?:*l#cu2mDÞg&F+"ʳi*},ތB*hO>EY{6/ vkR`e ̀Da~~ HQ Ly+)q͂Y(7^ n<=;eˢ~3$)<| R:וwzzԳ"tGz^E L\+}]Ҝ3,8Q闽h.,xܡ.g5{ѻCŽu){DPQ|-zuUR@N)f)Qh%EA rxVEQmTz .@Z8ƉwϺ PS3iUtnZ@,e2N24Kq{@= =ռ^z{{{{ĖOLAlwjb6T\h?IlD9=HRDOx c0NhB $(Lx`W,l KW۷;y7ۀ~go7Qv%-nVud2|:4"]2qb&.oB2zl!v"Ќ'ELp N3&7p("b F3H#8<J\xw2E{~6N2 ZaA3޳f&q4;?~7< (n9 (|Bj\HM=,Th?sѳkm8*ogԎؓ؉#DHK} `82OBqcgU-ΏZ;b ?mW?DA' ̀q\ybz3$.Y jeBB_7u0:l8QqsT7GQ񂄣樹9jn樹99^p4 7Gps4 7G[x +u98"GG[h?W_luV- +M-Cօ-AH&aȦYRD LfH>`$9iC4Ƈ=M}|?o>@HFZiHNp8r0(V`%&}qBL+u\C[ J,xI|FS@kzqy5[y,ZU=s2h, ^R\O}m>+rEbE KL6qKZ@3fg%J~|(7uhURvU˜Oig/^](9#G4}~X l؅Ǖ H v7mÖQx|hGt5"[X-絢M`N}o|>o5,U&5\_"P;G`^⚪7 q}:ۢM~{yNoS± o-zW ~44!z7=mÛ)78vRiG'wzfB?ktޡړm@k$=S3#zGtӅwc<>(JTO,!}v#}WoOz&Nj`db_r>"f*JXK TFT=qŎQ~N_UHV-ꭦ=_M#Zl&ڴ6V<[3[›Ľs7CjhCjh&ShhREC2Y%TG1F֜7Z4[dd&##2Zd=ɨVElaiF&osWYbi6]Mޡ6dcEoYlE󦷬Py C{#<`KFj%Ԏf!>RDvJ<?q_xeL`8%@/R3ŗAZIH:VOHa3+QWj&e 7[CAAbJjCA]lE溇ݥѐ0b@O̮vgo7p n p.zԠ5}nj(Z}ˏhv}uPA&Az8eI \l7.ul| >19Pv cRXoprtTm Ak%ƞ/r"/rra(63|Px>,e|pɇ|X6b9?^& %:tӉX.8✳E#y 9/9-RᫀUֆ+-Ro9-jYB/]y" mARK?pqPv8g.#ֺa[h\?v$"1,F%/oZ)xylf$f2+rR=* +(vTUD~ Xm{@#UaP1} 9|{Z&5OX.o\h'V}6*-VbQ)`CM-e4G+m{g-eZ\NoYD;,(RQnMOF2DYNHSz"ƥ2b\b!%m Fl=mF3Mu9LNTPDE*DcCk>3tN%9ǩ@^UXD#f^ŝo* A=XkIVcɤ#+z' 4kԠ%[W'^b~f0ozݓNprZR#xwxb׊=h w3ZqRY)4ey{wP9zfMUsvG IKG\S"7c((w`֑W*G+5I*CحG[ς؎]WĺixEM`ÇLGB>"Z2 VOh#UNcʲU+<0ִ[huD%+=䰇ăCQ V\$٨M:Ipl. 9C+zL%Y3|̛7y=aZGZ>0>j~b9'`b81q-x(gG>[t 51/cc;iv!)>y%CuP6j2xT wb$nV2f}A;h1iAsFDsӇƕ}gF06!)9/qJ;>$W$B܃Y3ؚMRKll ! ֤@޴OjP+P_'=*۵zg٦ xDڄueV1GY*'u%40? |_4!gͥ[R%WM9[=|vtg5uw dLEkwUWy{I^)%=W;ĐJlCd>%)Vyx̖dv*L)\6L\]]R)+7fYz;l!PUS]0C#ΉziH'|@_MIDx